CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 62.20% | +7.77% | — | |
| 2 | DSGN | Design Therapeutics INC | Stock-Other | 24.44% | -1.08% | +16.00% | |
| 3 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 9.37% | -3.10% | — | |
| 4 | NKTX | Nkarta INC | Stock-Other | 2.92% | -0.10% | — | |
| 5 | ✓ | Effector Therapeutics INC | Stock-Other | 1.07% | — | — |